Scarica l'app Stockscreener
2.58
3.61%
0.09
Precedente Chiudi:
$2.49
Aprire:
$2.54
Volume 24 ore:
1.65M
Relative Volume:
0.50
Capitalizzazione di mercato:
$125.10M
Reddito:
-
Utile/perdita netta:
$-82.44M
Rapporto P/E:
-1.3723
EPS:
-1.88
Flusso di cassa netto:
$-66.75M
1 W Prestazione:
+17.27%
1M Prestazione:
+76.11%
6M Prestazione:
+7.05%
1 anno Prestazione:
-44.52%
Intervallo 1D:
$2.50
$2.695
Intervallo di 1 settimana:
$2.195
$2.695
Portata 52W:
$1.195
$6.75
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
Nome
Black Diamond Therapeutics Inc
Settore
Industria
Telefono
617-417-5868
Indirizzo
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
Confronta BDTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BDTX
Black Diamond Therapeutics Inc
|
2.58 | 125.10M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
450.50 | 113.52B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
493.22 | 52.93B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
300.83 | 39.71B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
585.93 | 35.00B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
255.86 | 26.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-07-31 | Iniziato | Raymond James | Outperform |
| 2023-07-14 | Iniziato | Piper Sandler | Overweight |
| 2023-06-30 | Aggiornamento | Stifel | Hold → Buy |
| 2023-06-28 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2022-03-29 | Downgrade | Wedbush | Outperform → Neutral |
| 2022-03-22 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | Iniziato | Stifel | Hold |
| 2021-01-07 | Iniziato | Wedbush | Outperform |
| 2020-11-24 | Iniziato | Berenberg | Buy |
| 2020-05-04 | Iniziato | H.C. Wainwright | Buy |
| 2020-02-24 | Iniziato | Canaccord Genuity | Buy |
| 2020-02-24 | Iniziato | Cowen | Outperform |
| 2020-02-24 | Iniziato | JP Morgan | Overweight |
| 2020-02-24 | Iniziato | Jefferies | Buy |
Mostra tutto
Black Diamond Therapeutics Inc Borsa (BDTX) Ultime notizie
Squarepoint Ops LLC Buys 72,688 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Nuveen Asset Management LLC - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Purchased by Millennium Management LLC - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Northern Trust Corp - Defense World
Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference - GlobeNewswire
17,317 Shares in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Bought by D. E. Shaw & Co. Inc. - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) & Fresh Tracks Therapeutics (NASDAQ:FRTX) Critical Comparison - Defense World
Brokerages Set Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Price Target at $14.60 - Defense World
Black Diamond Therapeutics (NASDAQ:BDTX) Raised to Buy at Wall Street Zen - Defense World
Black Diamond Therapeutics Reports Strong Q1 2025 Earnings - TipRanks
3 Promising Penny Stocks With Market Caps Under $200M - Yahoo Finance
Price T Rowe Associates Inc. MD Cuts Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Wedbush Issues Optimistic Estimate for BDTX Earnings - Defense World
Dimensional Fund Advisors LP Has $1.42 Million Stake in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Raymond James Financial Inc. Makes New Investment in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Stifel Financial Corp Raises Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Wells Fargo & Company MN Buys 5,932 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics Inc (BDTX) Q1 2025 Earnings: Net Inco - GuruFocus
Black Diamond (BDTX) Strengthens Financial Position with Robust Cash Reserves | BDTX Stock News - GuruFocus
Black Diamond Therapeutics (BDTX) Surpasses Q1 Earnings Expectat - GuruFocus
What You Didn’t Know About Black Diamond Therapeutics Inc (NASDAQ: BDTX) This Week - Stocksregister
Hsbc Holdings PLC Has $59,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Barclays PLC Increases Stock Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics Reports Q1 2025 Financial Results and Updates on Clinical Trials for BDTX-1535 - Nasdaq
Black Diamond Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Skill-Knowledge-Conduct - TradingView
JPMorgan Chase & Co. Has $41,000 Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Market Momentum: Black Diamond Therapeutics Inc (BDTX) Registers a -12.28 Decrease, Closing at 1.47 - DWinneX
BlackRock, Inc. Reduces Stake in Black Diamond Therapeutics Inc - GuruFocus
Black Diamond Therapeutics Inc expected to post earnings of 20 cents a shareEarnings Preview - TradingView
Positive week for Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) institutional investors who lost 74% over the past year - Yahoo Finance
A History of Outperforming Analyst Forecasts and Beating the Odds: Black Diamond Therapeutics Inc (BDTX) - Sete News
Black Diamond Therapeutics Inc (BDTX) stock analysis: A comprehensive overview - uspostnews.com
Black Diamond Therapeutics Inc’s Banking’s 100-Day Moving Average at 2.0161: Will the Stock Break Through? - investchronicle.com
Geode Capital Management LLC Has $2.05 Million Holdings in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Financial Metrics Exploration: Understanding Black Diamond Therapeutics Inc (BDTX) Through Ratios - DWinneX
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Bought by Renaissance Technologies LLC - The AM Reporter
Black Diamond Therapeutics Inc (BDTX) presents a great opportunity, but the stock is slightly overvalued - uspostnews.com
Head-To-Head Contrast: Avalon GloboCare (NASDAQ:ALBT) and Black Diamond Therapeutics (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Shares Acquired by Wellington Management Group LLP - Defense World
Raymond James Financial Inc. Purchases New Position in Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Sei Investments Co. Purchases Shares of 22,802 Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
BDTX Stock Sees Decline of Approximately -12.66% in Last Five Days - knoxdaily.com
Black Diamond stock hits 52-week low at $1.42 amid challenges - Investing.com India
Black Diamond stock hits 52-week low at $1.42 amid challenges By Investing.com - Investing.com South Africa
Black Diamond Therapeutics Inc [BDTX] stock for 11,997,749 USD was sold by BIOTECH GROWTH N V - knoxdaily.com
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences - The Manila Times
Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Stock Holdings Raised by Intech Investment Management LLC - The AM Reporter
Bank of New York Mellon Corp Purchases 65,341 Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) - Defense World
Black Diamond Therapeutics’ Global Licensing Deal with Servier - Global Legal Chronicle
Black Diamond Therapeutics Inc Azioni (BDTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
1.51%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):